AUM111A ;IHS/SD/RNB - ICD 9 E CODES FOR FY 2012 ; [ 09/09/2010  8:30 AM ]
 ;;12.0;TABLE MAINTENANCE;;SEP 27,2011
 ;
ICD9NEW ;;ICD 9 DIAGNOSIS, NEW CODES: CODE NUMBER(#.01)^DIAGNOSIS(#3)^DESCRIPTION(#10)^USE WITH SEX(#9.5)^MDC(#5)^DRG(#60-65)^CC(#70)
 ;;041.41^Shiga txn-produce E.coli^Shiga toxin-producing Escherichia coli [E. coli] (STEC) O157^^18^867,868,869
 ;;041.42^Shga txn prod E.coli NEC^Other specified Shiga toxin-producing Escherichia coli [E. coli] (STEC)^^18^867,868,869^
 ;;041.43^Shga txn prod E.coli NOS^Shiga toxin-producing Escherichia coli [E. coli] (STEC), unspecified^^18^867,868,869^
 ;;041.49^E.coli infection NEC/NOS^Other and unspecified Escherichia coli [E. coli]^^18^867,868,869^
 ;;173.00^Malig neopl skin lip NOS^Unspecified malignant neoplasm of skin of lip^^9^606,607^
 ;;173.01^Basal cell ca skin lip^Basal cell carcinoma of skin of lip^^9^606,607^
 ;;173.02^Squamous cell ca skn lip^Squamous cell carcinoma of skin of lip^^9^606,607^
 ;;173.09^Malig neo skin lip NEC^Other specified malignant neoplasm of skin of lip^^9^606,607^
 ;;173.10^Mal neo eyelid/canth NOS^Unspecified malignant neoplasm of eyelid, including canthus^^2^124,125^
 ;;173.11^Basal cell ca lid/canth^Basal cell carcinoma of eyelid, including canthus^^2^124,125^
 ;;173.12^Squam cell ca lid/canth^Squamous cell carcinoma of eyelid, including canthus^^2^124,125^
 ;;173.19^Mal neo eyelid/canth NEC^Other specified malignant neoplasm of eyelid, including canthus^^2^124,125^
 ;;173.20^Malig neo skin ear NOS^Unspecified malignant neoplasm of skin of ear and external auditory canal^^9^606,607^
 ;;173.21^Basal cell ca skin ear^Basal cell carcinoma of skin of ear and external auditory canal^^9^606,607^
 ;;173.22^Squam cell ca skin ear^Squamous cell carcinoma of skin of ear and external auditory canal^^9^606,607^
 ;;173.29^Neo skin ear/ex canl NEC^Other specified malignant neoplasm of skin of ear and external auditory canal^^9^606,607^
 ;;173.30^Mal neo skn face NEC/NOS^Unspecified malignant neoplasm of skin of other and unspecified parts of face^^9^606,607^
 ;;173.31^Bsl cel skn face NEC/NOS^Basal cell carcinoma of skin of other and unspecified parts of face^^9^606,607^
 ;;173.32^Sqm cel skn face NEC/NOS^Squamous cell carcinoma of skin of other and unspecified parts of face^^9^606,607^
 ;;173.39^Mal neo skn face NEC/NOS^Other specified malignant neoplasm of skin of other and unspecified parts of face^^9^606,607^
 ;;173.40^Mal neo sclp/skn nck NOS^Unspecified malignant neoplasm of scalp and skin of neck^^9^606,607^
 ;;173.41^Bsl cell ca scalp/skn nk^Basal cell carcinoma of scalp and skin of neck^^9^606,607^
 ;;173.42^Sqam cell ca sclp/skn nk^Squamous cell carcinoma of scalp and skin of neck^^9^606,607^
 ;;173.49^Mal neo sclp/skn nck NEC^Other specified malignant neoplasm of scalp and skin of neck^^9^606,607^
 ;;173.50^Malig neo skin trunk NOS^Unspecified malignant neoplasm of skin of trunk, except scrotum^^9^606,607^
 ;;173.51^Basal cell ca skin trunk^Basal cell carcinoma of skin of trunk, except scrotum^^9^606,607^
 ;;173.52^Squam cell ca skin trunk^Squamous cell carcinoma of skin of trunk, except scrotum^^9^606,607^
 ;;173.59^Malig neo skin trunk NEC^Other specified malignant neoplasm of skin of trunk, except scrotum^^9^606,607^
 ;;173.60^Mal neo skin up limb NOS^Unspecified malignant neoplasm of skin of upper limb, including shoulder^^9^606,607^
 ;;173.61^Basal cell ca skn up lmb^Basal cell carcinoma of skin of upper limb, including shoulder^^9^606,607^
 ;;173.62^Squam cell ca skn up lmb^Squamous cell carcinoma of skin of upper limb, including shoulder^^9^606,607^
 ;;173.69^Malig neo skn up lmb NEC^Other specified malignant neoplasm of skin of upper limb, including shoulder^^9^606,607^
 ;;173.70^Mal neo skn low limb NOS^Unspecified malignant neoplasm of skin of lower limb, including hip^^9^606,607^
 ;;173.71^Basl cell ca skn low lmb^Basal cell carcinoma of skin of lower limb, including hip^^9^606,607^
 ;;173.72^Sqam cell ca skn low lmb^Squamous cell carcinoma of skin of lower limb, including hip^^9^606,607^
 ;;173.79^Mal neo skin low lmb NEC^Other specified malignant neoplasm of skin of lower limb, including hip^^9^606,607^
 ;;173.80^Mal neo skn site NEC/NOS^Unspecified malignant neoplasm of other specified sites of skin^^9^606,607^
 ;;173.81^Bsl cell ca skn site NEC^Basal cell carcinoma of other specified sites of skin^^9^606,607^
 ;;173.82^Sqm cell ca skn site NEC^Squamous cell carcinoma of other specified sites of skin^^9^606,607^
 ;;173.89^Oth mal neo skn site NEC^Other specified malignant neoplasm of other specified sites of skin^^9^606,607^
 ;;173.90^Malig neo skin site NOS^Unspecified malignant neoplasm of skin, site unspecified^^9^606,607^
 ;;173.91^Basal cell ca skin NOS^Basal cell carcinoma of skin, site unspecified^^9^606,607^
 ;;173.92^Squam cell ca skin NOS^Squamous cell carcinoma of skin, site unspecified^^9^606,607^
 ;;173.99^Oth mal neo skn site NOS^Other specified malignant neoplasm of skin, site unspecified^^9^606,607^
 ;;282.40^Thalassemia, unspecified^Thalassemia, unspecified^^15^791,793^
 ;;282.43^Alpha thalassemia^Alpha thalassemia^^15^791,793^
 ;;282.44^Beta thalassemia^Beta thalassemia^^15^791,793^
 ;;282.45^Delta-beta thalassemia^Delta-beta thalassemia^^15^791,793^
 ;;282.46^Thalassemia minor^Thalassemia minor^^15^791,793^
 ;;282.47^Hgb E-beta thalassemia^Hemoglobin E-beta thalassemia^^15^791,793^
 ;;284.11^Antin chemo indcd pancyt^Antineoplastic chemotherapy induced pancytopenia^^16^808,809,810^1
 ;;284.12^Oth drg indcd pancytopna^Other drug-induced pancytopenia^^16^808,809,810^1
 ;;284.19^Other pancytopenia^Other pancytopenia^^16^808,809,810^1
 ;;286.52^Acquired hemophilia^Acquired hemophilia^^16^813^1
 ;;286.53^Antiphospholipid w hemor^Antiphospholipid antibody with hemorrhagic disorder^^16^814,815,816^1
 ;;286.59^Ot hem d/t circ anticoag^Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors^^16^813^1
 ;;294.20^Demen NOS w/o behv dstrb^Dementia, unspecified, without behavioral disturbance^^19^884^
 ;;294.21^Demen NOS w behav distrb^Dementia, unspecified, with behavioral disturbance^^19^884^1
 ;;310.81^Pseudobulbar affect^Pseudobulbar affect^^1^56,57^
 ;;310.89^Nonpsych mntl disord NEC^Other specified nonpsychotic mental disorders following organic brain damage^^1^56,57^
 ;;331.6^Corticobasal degneration^Corticobasal degeneration^^1^56,57^
 ;;348.82^Brain death^Brain death^^1^80,81^1
 ;;358.30^Lambert-Eaton synd NOS^Lambert-Eaton syndrome, unspecified^^1^56,57^1
 ;;358.31^Lambert-Eaton synd neopl^Lambert-Eaton syndrome in neoplastic disease^^1^56,57^1
 ;;358.39^Lambert-Eaton syn ot dis^Lambert-Eaton syndrome in other diseases classified elsewhere^^1^56,57^1
 ;;365.05^Opn ang w brdrlne hi rsk^Open angle with borderline findings, high risk^^2^124,125^
 ;;365.06^Prim angle clos w/o dmg^Primary angle closure without glaucoma damage^^2^124,125^
 ;;365.70^Glaucoma stage NOS^Glaucoma stage, unspecified^^2^124,125^
 ;;365.71^Mild stage glaucoma^Mild stage glaucoma^^2^124,125^
 ;;365.72^Moderate stage glaucoma^Moderate stage glaucoma^^2^124,125^
 ;;365.73^Severe stage glaucoma^Severe stage glaucoma^^2^124,125^
 ;;365.74^Indeterm stage glaucoma^Indeterminate stage glaucoma^^2^124,125^
 ;;379.27^Vitreomacular adhesion^Vitreomacular adhesion^^2^124,125^
 ;;414.4^Cor ath d/t calc cor lsn^Coronary atherosclerosis due to calcified coronary lesion^^5^302,303^
 ;;415.13^Saddle embol pulmon art^Saddle embolus of pulmonary artery^^4^175,176^1
 ;;425.11^Hyprtrophc obst cardiomy^Hypertrophic obstructive cardiomyopathy^^5^314,315,316^1
 ;;425.18^Oth hyprtrophic cardiomy^Other hypertrophic cardiomyopathy^^5^314,315,316^1
 ;;444.01^Saddle embolus abd aorta^Saddle embolus of abdominal aorta^^5^299,300,301^
 ;;444.09^Ot art emb/thrm abd aort^Other arterial embolism and thrombosis of abdominal aorta^^5^299,300,301^1
 ;;488.81^Flu dt nvl A vrs w pneu^Influenza due to identified novel influenza A virus with pneumonia^^4^193,194,195^1
 ;;488.82^Flu dt nvl A w oth resp^Influenza due to identified novel influenza A virus with other respiratory manifestations^^4^193,194,195^
 ;;488.89^Flu dt novel A w oth man^Influenza due to identified novel influenza A virus with other manifestations^^18^865,866^
 ;;508.2^Resp cond dt smoke inhal^Respiratory conditions due to smoke inhalation^^4^205,206^
 ;;512.2^Postoperative air leak^Postoperative air leak^^4^199,200,201^1
 ;;512.81^Prim spont pneumothorax^Primary spontaneous pneumothorax^^4^199,200,201^1
 ;;512.82^Sec spont pneumothorax^Secondary spontaneous pneumothorax^^4^199,200,201^1
 ;;512.83^Chronic pneumothorax^Chronic pneumothorax^^4^199,200,201^1
 ;;512.84^Other air leak^Other air leak^^^4^199,200,201^1
 ;;512.89^Other pneumothorax^Other pneumothorax^^4^199,200,201^1
 ;;516.30^Idiopath inters pneu NOS^Idiopathic interstitial pneumonia, not otherwise specified^^4^196,197,198^
 ;;516.31^Idiopath pulmon fibrosis^Idiopathic pulmonary fibrosis^^4^196,197,198^
 ;;516.32^Idio non-spec inter pneu^Idiopathic non-specific interstitial pneumonitis^^4^196,197,198^
 ;;516.33^Acute interstitial pneum^Acute interstitial pneumonitis^^4^196,197,198^1
 ;;516.34^Resp brncio interst lung^Respiratory bronchiolitis interstitial lung disease^^4^196,197,198^
 ;;516.35^Idiopth lym interst pneu^Idiopathic lymphoid interstitial pneumonia^^4^196,197,198^1
 ;;516.36^Cryptogenic organiz pneu^Cryptogenic organizing pneumonia^^4^196,197,198^1
 ;;516.37^Desquamatv interst pneu^Desquamative interstitial pneumonia^^4^196,197,198^1
 ;;516.4^Lymphangioleiomyomatosis^Lymphangioleiomyomatosis^^4^196,197,198^1
 ;;516.5^Adlt pul Langs cell hist^Adult pulmonary Langerhans cell histiocytosis^^4^196,197,198^1
 ;;516.61^Neuroend cell hyprpl inf^Neuroendocrine cell hyperplasia of infancy^^4^196,197,198^1
 ;;516.62^Pulm interstitl glycogen^Pulmonary interstitial glycogenosis^^4^196,197,198^1
 ;;516.63^Surfactant mutation lung^Surfactant mutations of the lung^^4^196,197,198^1
 ;;516.64^Alv cap dysp w vn misaln^Alveolar capillary dysplasia with vein misalignment^^4^196,197,198^1
 ;;516.69^Oth intrst lung dis chld^Other interstitial lung diseases of childhood^^4^196,197,198^1
 ;;518.51^Ac resp flr fol trma/srg^Acute respiratory failure following trauma and surgery^^4^189^1
 ;;518.52^Ot pul insuf fol trm/srg^Other pulmonary insufficiency, not elsewhere classified, following trauma and surgery^^4^189^1
 ;;518.53^Ac/chr rsp flr fol tr/sg^Acute and chronic respiratory failure following trauma and surgery^^4^189^1
 ;;539.01^Inf d/t gastrc band proc^Infection due to gastric band procedure^^6^393,394,395^1
 ;;539.09^Oth cmp gastrc band proc^Other complications of gastric band procedure^^6^393,394,395^1
 ;;539.81^Inf d/t ot bariatrc proc^Infection due to other bariatric procedure^^6^393,394,395^1
 ;;539.89^Ot comp ot bariatrc proc^Other complications of other bariatric procedure^^6^393,394,395^1
 ;;573.5^Hepatopulmonary syndrome^Hepatopulmonary syndrome^^4^205,206^
 ;;596.81^Infection of cystostomy^Infection of cystostomy^^11^698,699,700^1
 ;;596.82^Mech comp of cystostomy^Mechanical complication of cystostomy^^11^698,699,700^1
 ;;596.83^Other comp of cystostomy^Other complication of cystostomy^^11^698,699,700^1
 ;;596.89^Disorders of bladder NEC^Other specified disorders of bladder^^11^698,699,700^
 ;;629.31^Eros imp vag mesh in tis^Erosion of implanted vaginal mesh and other prosthetic materials to surrounding organ or tissue^^13^742,743,760,761^
 ;;629.32^Exp imp vag mesh-vagina^Exposure of implanted vaginal mesh and other prosthetic materials into vagina^^13^742,743,760,761^
 ;;631.0^Inapp chg hCG early preg^Inappropriate change in quantitative human chorionic gonadotropin (hCG) in early pregnancy^^14^781,782^
 ;;631.8^Oth abn prod conception^Other abnormal products of conception^^14^781,782^
 ;;649.81^Spon labr w plan C/S-del^Onset (spont) of labor after 37 comp weeks of gestation but before 39 comp weeks gestation, with delivery by (planned) c-section, delivered, w/wo mention of antepartum condition^^14^765,766,767,768,774,775^
 ;;649.82^Lbr w plan C/S-del w p/p^Onset (spont) of labor after 37 comp weeks of gestation but before 39 comp weeks gestation, with delivery by (planned) c-section, delivered, with mention of postpartum complication^^14^765,766,767,768,774,775^
 ;;704.41^Pilar cyst^Pilar cyst^^9^606,607^
 ;;704.42^Trichilemmal cyst^Trichilemmal cyst^^9^606,607^
 ;;726.13^Partial tear rotatr cuff^Partial tear of rotator cuff^^8^557,558^
 ;;747.31^Pulmon art coarct/atres^Pulmonary artery coarctation and atresia^^5^306,307^1
 ;;747.32^Pulmonary AV malformatn^Pulmonary arteriovenous malformation^^5^306,307^1
 ;;747.39^Oth anom pul artery/circ^Other anomalies of pulmonary artery and pulmonary circulation^^5^306,307^1
 ;;793.11^Solitary pulmonry nodule^Solitary pulmonary nodule^^4^205,206^
 ;;793.19^Ot nonsp ab fnd lung fld^Other nonspecific abnormal finding of lung field^^4^204^
 ;;795.51^Nonsp rea skn test wo tb^Nonspecific reaction to tuberculin skin test without active tuberculosis^^4^177,178,179^
 ;;795.52^Nonsp rea gma interferon^Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis^^4^177,178,179^
 ;;808.44^Cl skl vlt fx-proln coma^Multiple closed pelvic fractures without disruption of pelvic circle^^8^535,536^1
 ;;808.54^Opn skl vlt fx-proln com^Multiple open pelvic fractures without disruption of pelvic circle^^8^535,536^1
 ;;END
PRNT ;;
 S U="^"
 W !," CODE",?10,"DIAGNOSIS",!?10,"DESCRIPTION",!," -----",?10,"-----------"
 NEW X,Y,P2,P3
 F X=1:1 S Y=$P($T(ICD9NEW+X),";;",3),P2=$P(Y,U,2),P3=$P(Y,U,3) Q:Y="END"  W !," ",$P(Y,U,1),?10,$S($L(P3):P3,1:P2),!?10,P2
 Q
